Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Tricuspid Regurgitation Treatment With LAPLACE Transcatheter Tricuspid Valve Replacement System

The objective of this clinical study is to assess the safety and efficacy of the Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System for the treatment of symptomatic subjects with at least severe tricuspid regurgitation (TR).

Participants needed: 700
Trial details
Age: 18-90Biological sex: AllType: InterventionalSponsor: Laplace Interventional, IncUpdated: Jul 22, 2026
Eligibility criteria

18 - 90 years of age at the time of the study procedure. [+5]

Estimated life expectancy of less than 12 months. [+8]

Status: Recruiting

Laplace Early Feasibility Study - Canada

The objective of the study is to assess the safety and technical feasibility of the Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System

Participants needed: 15
Trial details
Age: 60-90Biological sex: AllType: InterventionalSponsor: Laplace Interventional, IncUpdated: Jul 22, 2026Locations: 3
Eligibility criteria

60 - 90 years of age at the time of the study procedure [+4]

Estimated life expectancy of less than 12 months [+27]

Status: Recruiting

Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System

The objective of the study is to assess the safety and technical feasibility of the Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System

Participants needed: 65
Trial details
Age: 18-90Biological sex: AllType: InterventionalSponsor: Laplace Interventional, IncUpdated: Jul 23, 2026Locations: 10
Eligibility criteria

18 - 90 years of age at the time of the study procedure [+5]

Estimated life expectancy of less than 12 months [+13]